Bristlecone Advisors, LLC Amgen Inc Transaction History

Bristlecone Advisors, LLC

$1.24 Billion
Q3 2024

A detailed history of Bristlecone Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Bristlecone Advisors, LLC holds 17,697 shares of AMGN stock, worth $4.66 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

17,697

Previous 17,851 0.86%

Holding current value

$4.66 Million

Previous $5.58 Million 2.24%

% of portfolio

0.46%

Previous 0.48%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$309.38 - $337.38 $47,644 - $51,956	-154 Reduced 0.86%	17,697 $5.7 Million
Q2 2024 Jul 25, 2024	SELL	$262.75 - $319.31 $26,012 - $31,611	-99 Reduced 0.55%	17,851 $5.58 Million
Q1 2024 Apr 22, 2024	BUY	$268.87 - $324.56 $122,873 - $148,323	457 Added 2.61%	17,950 $5.1 Million
Q4 2023 Jan 25, 2024	SELL	$255.7 - $288.46 $95,120 - $107,307	-372 Reduced 2.08%	17,493 $5.04 Million
Q3 2023 Oct 16, 2023	BUY	$218.65 - $271.46 $116,321 - $144,416	532 Added 3.07%	17,865 $4.8 Million
Q2 2023 Aug 03, 2023	SELL	$214.27 - $253.37 $188,986 - $223,472	-882 Reduced 4.84%	17,333 $3.85 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $228,951 - $279,052	1,014 Added 5.9%	18,215 $4.4 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $83,595 - $106,218	-365 Reduced 2.08%	17,201 $4.52 Million
Q3 2022 Oct 27, 2022	BUY	$224.46 - $253.15 $19,079 - $21,517	85 Added 0.49%	17,566 $3.96 Million
Q2 2022 Jul 25, 2022	BUY	$230.71 - $256.74 $556,933 - $619,770	2,414 Added 16.02%	17,481 $4.25 Million
Q1 2022 Apr 22, 2022	BUY	$219.27 - $242.57 $3,508 - $3,881	16 Added 0.11%	15,067 $3.64 Million
Q4 2021 Jan 19, 2022	SELL	$198.88 - $227.6 $676,987 - $774,750	-3,404 Reduced 18.44%	15,051 $3.39 Million
Q3 2021 Oct 19, 2021	BUY	$212.27 - $248.7 $16,981 - $19,896	80 Added 0.44%	18,455 $3.92 Million
Q2 2021 Jul 21, 2021	SELL	$233.58 - $259.14 $118,191 - $131,124	-506 Reduced 2.68%	18,375 $4.48 Million
Q1 2021 Apr 30, 2021	SELL	$221.91 - $258.6 $4,438 - $5,172	-20 Reduced 0.11%	18,881 $4.7 Million
Q4 2020 Jan 25, 2021	BUY	$216.38 - $257.67 $32,240 - $38,392	149 Added 0.79%	18,901 $4.35 Million
Q3 2020 Oct 20, 2020	SELL	$234.65 - $260.95 $116,386 - $129,431	-496 Reduced 2.58%	18,752 $4.77 Million
Q2 2020 Jul 16, 2020	SELL	$197.81 - $242.74 $23,341 - $28,643	-118 Reduced 0.61%	19,248 $4.54 Million
Q1 2020 Apr 16, 2020	SELL	$182.24 - $241.7 $303,976 - $403,155	-1,668 Reduced 7.93%	19,366 $3.93 Million
Q4 2019 Jan 21, 2020	BUY	$189.21 - $243.2 $267,353 - $343,641	1,413 Added 7.2%	21,034 $5.07 Million
Q3 2019 Oct 28, 2019	SELL	$174.11 - $208.62 $272,133 - $326,073	-1,563 Reduced 7.38%	19,621 $3.8 Million
Q2 2019 Jul 19, 2019	BUY	$166.7 - $195.41 $263,886 - $309,334	1,583 Added 8.08%	21,184 $3.9 Million
Q1 2019 Apr 23, 2019	BUY	$180.87 - $203.88 $24,417 - $27,523	135 Added 0.69%	19,601 $3.72 Million
Q4 2018 Jan 15, 2019	SELL	$178.4 - $208.25 $38,356 - $44,773	-215 Reduced 1.09%	19,466 $3.79 Million
Q3 2018 Oct 22, 2018	BUY	$185.29 - $208.89 $1.34 Million - $1.51 Million	7,250 Added 58.32%	19,681 $4.08 Million
Q2 2018 Jul 31, 2018	SELL	$166.05 - $186.51 $218,521 - $245,447	-1,316 Reduced 9.57%	12,431 $2.3 Million
Q1 2018 Apr 24, 2018	SELL	$169.43 - $198.0 $576,062 - $673,200	-3,400 Reduced 19.83%	13,747 $2.34 Million
Q4 2017 Jan 30, 2018	BUY	$168.79 - $188.59 $52,324 - $58,462	310 Added 1.84%	17,147 $2.98 Million
Q3 2017 Oct 20, 2017	BUY	$167.29 - $191.0 $2.82 Million - $3.22 Million	16,837	16,837 $3.14 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bristlecone Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bristlecone Advisors, LLC with notifications on news.

Account

Bristlecone Advisors, LLC Amgen Inc Transaction History